Copyright
©The Author(s) 2022.
World J Clin Oncol. May 24, 2022; 13(5): 366-375
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.366
Published online May 24, 2022. doi: 10.5306/wjco.v13.i5.366
Table 1 Comparison of demographic and clinical parameters of patients who underwent laparoscopic pancreatoduodenectomy with binding pancreaticogastrostomy and modified Blumgart pancreaticojejunostomy
| Variable | Binding PG group, n = 25 | Modified Blumgart PJ group, n = 25 | P value |
| Age in yr, median (range) | 53.7 (37-75) | 58.2 (31-79) | 0.12 |
| Sex, Male:Female | 14:11 | 15:10 | > 0.99 |
| BMI in kg/m2, median (range) | 23.8 (17.6-41.6) | 24.6 (18.2-40.0) | 0.69 |
| Jaundice, n (%) | 22 (88) | 21 (84) | > 0.99 |
| Cholangitis, n (%) | 8 (32) | 5 (20) | 0.52 |
| Peak total bilirubin levels in mg/dL, median (range) | 12.8 (1.2-28.3) | 10.6 (1.1-31.2) | 0.59 |
| Preoperative biliary drainage, n (%) | 14 (56) | 12 (48) | 0.78 |
| CA 19-9 (U/mL), median (range) | 55 (1-5682) | 84 (2-3318) | 0.12 |
| Diagnosis, n (%) | |||
| Cholangiocarcinoma | 9 (36) | 7 (28) | 0.76 |
| Pancreatic adenocarcinoma | 3 (12) | 2 (8) | > 0.99 |
| Ampullary adenocarcinoma | 7 (28) | 9 (36) | 0.76 |
| Duodenal adenocarcinoma | 3 (12) | 4 (16) | > 0.99 |
| Intraductal papillary mucinous | 2 (8) | 1 (4) | > 0.99 |
| Neoplasm pancreas | |||
| Neuroendocrine tumor | 1 (4) | 2 (8) | > 0.99 |
Table 2 Comparison of perioperative outcomes of patients who underwent laparoscopic pancreatoduodenectomy with binding pancreaticogastrostomy and modified Blumgart pancreaticojejunostomy
| Variable | Binding PG group, n = 25 | Modified Blumgart PJ group, n = 25 | P value |
| Total operative time in min, median (range) | 445 (390-710) | 405 (330-670) | 0.06 |
| Operative time for pancreatic reconstruction in min, median (range) | 42 (26-65) | 58 (44-81) | 0.01 |
| Estimated blood loss in mL, median (range) | 320 (210-740) | 310 (175-950) | 0.09 |
| Blood Transfusion, n (%) | 6 (24) | 7 (28) | > 0.99 |
| Gland texture, n (%) | |||
| Soft | 17 (68) | 19 (76) | 0.75 |
| Firm | 8 (32) | 6 (24) | |
| Pancreatic duct diameter in mm, median (range) | 3 (1-9) | 3 (2-10) | > 0.99 |
| Fistula risk score, n (%) | |||
| Low | 5 (20) | 7 (28) | 0.74 |
| Intermediate | 12 (48) | 13 (52) | > 0.99 |
| High | 8 (32) | 5 (20) | 0.52 |
| Postoperative morbidity, Clavien-Dindo classification IIIa or more, n (%) | 8 (32) | 9 (36) | > 0.99 |
| Pancreatic fistula as Grade B/C, n (%) | 1 (4) | 7 (28) | 0.04 |
| Delayed gastric emptying, n (%) | 7(28) | 6 (24) | > 0.99 |
| Post pancreatectomy hemorrhage, n (%) | 8 (32) | 1 (4) | 0.02 |
| Bile leak, n (%) | 0 | 1 (4) | > 0.99 |
| Postoperative hospital stay in days, median (range) | 9 (6-38) | 8 (5-56) | 0.72 |
- Citation: Choudhury SR, Kalayarasan R, Gnanasekaran S, Pottakkat B. Modified binding pancreaticogastrostomy vs modified Blumgart pancreaticojejunostomy after laparoscopic pancreaticoduodenectomy for pancreatic or periampullary tumors. World J Clin Oncol 2022; 13(5): 366-375
- URL: https://www.wjgnet.com/2218-4333/full/v13/i5/366.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i5.366